1-3 of 3
Authors: Sara Ferrando-Martinez
Sort by
Journal Article
CTIM-30. NT-I7, A LONG-ACTING INTERLEUKIN-7, PROMOTES ACTIVATION, CYTOTOXIC FUNCTION, AND SELECTIVE CLONOTYPE EXPANSION OF CD8+ T CELLS IN PATIENTS WITH HIGH GRADE GLIOMAS Free
Kaiden Barozinsky and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii92, https://doi.org/10.1093/neuonc/noae165.0363
Published: 11 November 2024
Journal Article
CTIM-24. PHASE II TRIAL OF RHIL-7-HYFC IN PATIENTS WITH HIGH-GRADE GLIOMA DEMONSTRATED ACCEPTABLE SAFETY PROFILE AND REDUCED LYMPHOPENIA Free
Yuping Derek Li and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii90–viii91, https://doi.org/10.1093/neuonc/noae165.0357
Published: 11 November 2024
Journal Article
EXTH-52. LONG-ACTING RECOMBINANT INTERLEUKIN-7, NT-I7, IMPROVES SURVIVAL FOLLOWING ONCOLYTIC ZIKA VIRUS TREATMENT IN THE SB28 IMMUNOSUPPRESSIVE AND TREATMENT-RESISTANT MURINE GLIOMA MODEL Free
Yuping Li and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v236, https://doi.org/10.1093/neuonc/noad179.0905
Published: 10 November 2023
Advertisement
Advertisement